Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”) Feb 02, 2021
Checkpoint Therapeutics to Participate in Three January 2021 Virtual Investor Conferences Jan 06, 2021
